Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Neeraj Raghunath

Pediatric Gastroenterology Hollywood, FL Medical Doctor

NPI 1275855595 CMS profile 1140816

1150 N 35Th Ave, Suite 545, Hollywood, FL 33021

Open in the dashboard

General payments

$5,042

201 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Neeraj Raghunath of Hollywood, FL is reported in the CMS Open Payments database as having received $5,042 across 201 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 83rd percentile of Pediatric Gastroenterology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,266 46
2024 General $1,198 42
2023 General $778 31
2022 General $487 18
2021 General $365 19
2020 General $501 24
2019 General $447 21

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Neeraj Raghunath
  • Pediatric Gastroenterology median
  • Middle half of Pediatric Gastroenterology
  • National median

In program year 2025, general payments to Neeraj Raghunath were reported at $1,266. Among 1,132 Pediatric Gastroenterology profiles paid that year, the median was $194 and the middle half received between $81 and $540.

Show as a table
Year Neeraj Raghunath Pediatric Gastroenterology median Middle half National median
2019 $447 $131 $41–$311 $163
2020 $501 $79 $23–$223 $114
2021 $365 $104 $32–$321 $132
2022 $487 $125 $37–$331 $149
2023 $778 $169 $55–$440 $160
2024 $1,198 $196 $73–$563 $164
2025 $1,266 $194 $81–$540 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Janssen Biotech, Inc. $1,349 47 payments
  2. AbbVie, Inc. $961 38 payments
  3. QOL Medical, LLC $662 43 payments
  4. Genzyme Corporation $603 24 payments
  5. Ipsen Biopharmaceuticals, Inc $272 13 payments
  6. Takeda Pharmaceuticals U.S.A., Inc. $270 12 payments
  7. Regeneron Healthcare Solutions, Inc. $263 5 payments
  8. Alcresta Therapeutics, Inc. $121 1 payment
  9. Janssen Scientific Affairs, LLC $110 1 payment
  10. Innovative Health Solutions, Inc. $81 1 payment
  11. Other $352 16 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $4,745 198 payments
  2. Education $297 3 payments
Products named General payments · program years 2019–2025
  1. STELARA $1,234 42 payments
  2. HUMIRA $665 30 payments
  3. DUPIXENT $603 24 payments
  4. TREMFYA $447 16 payments
  5. SIMPONI ARIA $307 14 payments
  6. SIMPONI $307 14 payments
  7. RINVOQ $299 8 payments
  8. Sucraid Therapy For Csid $292 17 payments
  9. Bylvay $272 13 payments
  10. Sucraid Therapy For Csid $255 20 payments
  11. Other $1,448 50 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

201 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatric Gastroenterology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record